SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (18367)1/29/1999 7:43:00 PM
From: Mkilloran  Read Replies (1) of 23519
 
Vlad...if you were the head of the partner company and had to pay xxx millions to get the sales rights to Muse in the USA and Japan...you could also buy on the open market up to 5% of Vivus stock about 1.5 million shares in the $2.50 to $5 range if you do it over a month or so quietly. My understanding is the partner would only have to file a 13d report with the sec after they have acquired %5 of a company stock.

1.5 mill at adv $4...for $6 mill could be a quick jump to $8 stock value ($6 mill gain) to offset your cash investment. And lead to more in the future.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News